PHARMECEUTICAL COMPOSITION FOR LUNG CANCER TREATMENT AND METHODS FOR PROVIDING INFORMATION AND SCREENING
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Mar 14, 2019
app pub date -
Jan 6, 2016
filing date -
Jan 6, 2016
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
A pharmaceutical composition containing a lung cancer therapeutic agent and an SIRT inhibitor may minimize the expression of the resistance of lung cancer cells against the lung cancer therapeutic agent, thereby exerting an excellent lung cancer therapeutic effect. The treatment of lung cancer cells with a lung cancer therapeutic agent and the measurement of a level of SIRT1 expression may provide information for determining whether lung cancer cells have developed chemoresistance to a lung cancer therapeutic agent, and may screen lung cancer therapeutic agents.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully